Filing Details
- Accession Number:
- 0001140361-17-037087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-02 15:04:37
- Reporting Period:
- 2017-09-29
- Accepted Time:
- 2017-10-02 15:04:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
868278 | Prophase Labs Inc. | PRPH | Pharmaceutical Preparations (2834) | 232577138 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1373603 | Michael Braden Leonard | 65 E Cedar - Suite 2 Zionsville IN 46077 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-09-29 | 1,695,305 | $2.30 | 627,322 | No | 4 | S | Indirect | Holding of BML Investment Partners, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Holding of BML Investment Partners, L.P. |
Footnotes
- 1. These shares were sold to the Issuer through the tender offer by the Issuer for 4,000,000 shares of its common stock.
- BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.